semaglutide ckd approval Recent medical milestones include the **2025 FDA approval** of **Ozempic ( semaglutide)** specifically to slow the Long-term kidney outcomes of semaglutide

Biosimilars are like generic drugs

These products typically contain specific bacterial strainsmost commonly Akkermansia muciniphila , Lactobacillus species, and Bifidobacterium strainsthat manufacturers claim can stimulate the body's natural production of glucagon-like peptide-1 (GLP-1)

Platforms promoting hers glp1 or hers tirzepatide can make microdosing seem simple

Earlier dual-agonist research (combining GLP-1 with glucagon) had explored these benefits but was hampered by hyperglycemia

What makes RescueMD different from other clinics

10.1038/s41467-018-04422-2 90 LuretteO.Martn-JimnezR.KhanM.ShetaR.JeanS.SchofieldM.et al (2023)